ArticleThe Journal of rheumatology2022

An Evidence-Based Guideline Improves Outcomes for Patients With Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome.

Maria L Taylor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.